Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
462.60    -5.00 (-1.07%)
Bid:
465.80
Ask:
466.40
Spread: 0.60 (0.129%)
Market Cap: £2.37b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Directorate Change

23 Mar 2023 17:00

RNS Number : 0614U
QinetiQ Group plc
23 March 2023
 

QinetiQ Group plc

 

Board Changes

 

23 March 2023 - QinetiQ Group plc ('QinetiQ') today announces that Michael Harper, who has been a Non-executive Director since November 2011; and Deputy Chair and Senior Independent Director since January 2012, is to retire from the Board with effect from the conclusion of the 2023 Annual General Meeting ("AGM").

 

Following Michael's retirement, Steve Mogford, Non-executive Director, will become the Group's Senior Independent Director ("SID").

 

Commenting on today's announcement, Neil Johnson, Group Chair of QinetiQ, said:

 

"I would like to thank Michael for his consistently invaluable contribution to both the Board and the wider QinetiQ family. As Deputy Chair and SID, his wise counsel and the sharing of his wealth of experience, has been appreciated by all who have worked with him in pursuit of QinetiQ's global growth strategy. On a personal note, I would particularly like to thank Michael for his support, guidance and advice when I joined the Board, and subsequently as an outstanding SID and valued sounding board. He will be missed, and we all wish him well in a richly deserved retirement."

 

"We are indeed fortunate to have Steve Mogford, a Board member since August 2022, available to take on the SID role as Michael retires. Since joining the Board, Steve has brought the benefit of his wealth of experience in both executive and non-executive roles across a breadth of sectors, including international defence and security. This has enhanced the skill sets of our Board, and means he is extremely well equipped to take on the additional challenges of this role. I very much look forward to working with Steve as SID following the AGM."

 

9.6.11R of the Listing Rules of the UK Listing Authority:

 

This notice is given in fulfilment of the obligation under paragraph 9.6.11R of the Listing Rules. There are no other matters requiring disclosure under paragraph 9.6.11R.

 

S430(2B) Companies Act 2006:

 

Michael Harper has not and will not receive any loss of office payments, nor will he be paid any further remuneration for his service as a Director of QinetiQ Group plc, other than fees due for his services up to the date he retires from the Board.

 

About QinetiQ:

 

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

 

For further information please contact:

 

John Haworth, Group Head of Investor Relations: +44 (0) 7920 545841

James Field, Company Secretary: +44 (0) 7841 662957

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEXLFLXXLFBBX
Date   Source Headline
10th Nov 202212:13 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSSecond Quarter Trading Update
11th Oct 20223:28 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:06 amRNSAcquisition of Air Affairs & disposal of Space NV
12th Sep 20223:28 pmRNSDirector/PDMR Shareholding
26th Aug 202212:53 pmRNSDirector/PDMR Shareholding
10th Aug 20223:36 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSDelivering growth in the US with $45m contract win
5th Aug 20226:22 pmRNSProposed Acquisition of Avantus Federal LLC
1st Aug 20223:19 pmRNSHolding(s) in Company
21st Jul 20223:18 pmRNSResult of AGM
21st Jul 20227:00 amRNSFirst Quarter Trading Update
19th Jul 20225:24 pmRNSHolding(s) in Company
12th Jul 20222:09 pmRNSHolding(s) in Company
12th Jul 20221:47 pmRNSDirector/PDMR Shareholding
29th Jun 20225:09 pmRNSDirector/PDMR Shareholding
27th Jun 202212:35 pmRNSHolding(s) in Company
15th Jun 20229:53 amRNSHolding(s) in Company
13th Jun 202212:59 pmRNSDirector/PDMR Shareholding
13th Jun 202212:28 pmRNSAnnual Financial Report
6th Jun 202210:52 amRNSHolding(s) in Company
30th May 202212:03 pmRNSNotification of Major Shareholding
23rd May 20227:00 amRNSConfirmation of Full Year Results
19th May 20227:00 amRNSPreliminary Results
18th May 20227:00 amRNSDirectorate Change
17th May 202211:24 amRNSHolding(s) in Company
16th May 20221:45 pmRNSHolding(s) in Company
10th May 202211:49 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSInvestor Seminar: Delivering our global ambition
26th Apr 20221:37 pmRNSHolding(s) in Company
21st Apr 20229:15 amRNSHolding(s) in Company
20th Apr 20227:00 amRNSFourth Quarter Trading Update
12th Apr 202212:45 pmRNSDirector/PDMR Shareholding
10th Mar 202211:27 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
2nd Feb 20228:42 amRNSHolding(s) in Company
24th Jan 202211:12 amRNSDirector/PDMR Shareholding
19th Jan 20221:43 pmRNSHolding(s) in Company
18th Jan 20227:00 amRNSThird Quarter Trading Update
17th Jan 20227:00 amRNSAppointment of President and CEO of QinetiQ US
11th Jan 202211:43 amRNSDirector/PDMR Shareholding
5th Jan 20225:05 pmRNSDirector/PDMR Shareholding
20th Dec 20219:21 amRNSDirector Declaration
10th Dec 202112:42 pmRNSDirector/PDMR Shareholding
6th Dec 202112:16 pmRNSHolding(s) in Company
18th Nov 202111:04 amRNSDirector/PDMR Shareholding
17th Nov 202110:54 amRNSDirector/PDMR Shareholding
16th Nov 202111:24 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.